VBI Vaccines Overview

VBI Vaccines Cost of Revenue

Cost of Revenue analysis for VBIV.

Quarterly Cost of Revenue

$2.72M

↓ 23.46% YoY

As of Mar 31, 2024

Annual Cost of Revenue (TTM)

$12.15M

↑ 0.56% YoY

Trailing 12 months ending Mar 31, 2024

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin